The Impact of Iris Color on the Efficacy of Low-Concentration Atropine in Controlling Myopia Progression - Scorecard - MDSpire

The Impact of Iris Color on the Efficacy of Low-Concentration Atropine in Controlling Myopia Progression

  • By

  • Gareth Lingham

  • James Loughman

  • Samantha SY Lee

  • Michael X. Repka

  • Eoin Kerin

  • Alicia Gómez Sánchez

  • Emmanuel Kobia-Acquah

  • Ernest Kyei Nkansah

  • Ian Flitcroft

  • David A. Mackey

  • April 27, 2026

  • 0 min

Share

Clinical Scorecard: The Impact of Iris Color on the Efficacy of Low-Concentration Atropine in Controlling Myopia Progression

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target PopulationChildren and adolescents of various ethnic backgrounds, with a focus on European descent.
Care Setting

Key Highlights

  • Include a note on the variability of treatment effects across different ethnicities.

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

      • Regularly evaluate ocular parameters such as axial length and accommodative amplitude every 6 months.

      Risks

        Patient & Prescribing Data

        Atropine 0.05% shows favorable efficacy across diverse populations without significant adverse effects.

        Clinical Best Practices

        • Incorporate long-term follow-up assessments to evaluate the sustainability of treatment effects.

        References

        Original Source(s)

        Related Content